GlassScriptPhysician profile
Hailey S Campbell
NPI 1447655972
$3,823.72
in general payments reported to CMS, 2019-2025
45 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $311 · 2022: $630 · 2023: $894 · 2024: $911 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,882.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $644.10 | 2021-2025 | |
| Ucb, INC. | $519.28 | 2022-2025 | Fintepla, Briviact, Rystiggo |
| Lundbeck LLC | $290.12 | 2022-2025 | Vyepti, Rexulti |
| Emd Serono, INC. | $184.33 | 2021-2025 | Mavenclad |
| Biogen, INC. | $179.25 | 2021-2024 | Spinraza, Vumerity, Tysabri |
| Alexion Pharmaceuticals, INC. | $138.98 | 2021-2025 | Ultomiris, Soliris |
| Novartis Pharmaceuticals Corporation | $131.57 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $130.45 | 2023-2025 | Daybue, Nuplazid |
| Tg Therapeutics, INC. | $127.80 | 2023-2025 | |
| Catalyst Pharmaceuticals, INC. | $106.17 | 2023-2025 | Fycompa, Firdapse |
| Takeda Pharmaceuticals U.S.A., INC. | $101.32 | 2024-2025 | Hyqvia, Fruzaqla |
| Teva Pharmaceuticals USA, INC. | $95.20 | 2021-2022 | |
| Harmony Biosciences LLC | $92.17 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $89.66 | 2023-2025 | Dysport |
| Jazz Pharmaceuticals INC. | $75.23 | 2022-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hailey Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.